Market Exclusive

ANTHEM, INC. (NYSE:ANTM) Files An 8-K Results of Operations and Financial Condition

ANTHEM, INC. (NYSE:ANTM) Files An 8-K Results of Operations and Financial Condition

Item2.02Results of Operations and Financial Condition

Officers of Anthem, Inc. (the Company) will speak with securities
analysts and investors on January10-11, 2017. During these
meetings, Company officers intend to discuss preliminary 2016
financial results.

The Company currently expects full year 2016 net income to be
approximately $9.21 per share and full year 2016 adjusted net
income to be approximately $11.00 per share, excluding net
unfavorable items of $1.79 per share, as listed in the table
below:


FullYear2016 Outlook


Net income per diluted share

~$ 9.21


Add / (Subtract):


Net realized (gains)/losses on investments

(0.02 )


Other-than-temporary impairment losses on investments
recognized in income

0.43


Transaction related costs

1.20


Deferred tax asset write-off from California tax
legislation

0.08


Amortization of other intangible assets

0.72


Tricare bid conclusion costs

0.14


Tax impact of non-GAAP adjustments

(0.76 )


Net adjustment items

1.79


Adjusted net income per diluted share

~$ 11.00

The increase in the Companys full year 2016 adjusted net income
outlook primarily reflects the favorable impact of a retroactive
change in minimum MLR calculation under Californias Medicaid
expansion program.

In addition, the officers will discuss the Companys 2016 year-end
medical enrollment, which is expected to be approximately
39.9million members, which is ahead of the Companys earlier
expectations.

The Company expects to release detailed 2016 financial results on
February1, 2017.

Section7Regulation FD

Item7.01Regulation FD Disclosure

See the information in Item2.02 above, which is incorporated
herein by reference.

None of the information furnished in Item2.02 or Item7.01 hereto
shall be deemed to be filed for purposes of Section18 of the
Securities Exchange Act of 1934, as amended. Unless expressly set
forth by specific reference in such filings, none of the
information furnished in this report shall be incorporated by
reference in any filing under the Securities Act of 1933, as
amended, whether made before or after the date hereof and
regardless of any general incorporation language in such filings.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995

This document contains certain forward-looking information
about us that is intended to be covered by the safe harbor for
forward-looking statements provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are
generally not historical facts. Words such as expect, feel,
believe, will, may, should, anticipate, intend, estimate,
project, forecast, plan and similar expressions are intended to
identify forward-looking statements. These statements include,
but are not limited to: financial projections and estimates and
their underlying assumptions; statements regarding plans,
objectives and

expectations with respect to future operations, products and
services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many
of which are difficult to predict and generally beyond our
control, that could cause actual results to differ materially
from those expressed in, or implied or projected by, the
forward-looking statements. These risks and uncertainties
include: those discussed and identified in our public filings
with the U.S. Securities and Exchange Commission, or SEC;
increased government participation in, or regulation or taxation
of health benefits and managed care operations, including, but
not limited to, the impact of the Patient Protection and
Affordable Care Act and the Health Care and Education
Reconciliation Act of 2010, or Health Care Reform; trends in
health care costs and utilization rates; our ability to secure
sufficient premium rates including regulatory approval for and
implementation of such rates; our participation in federal and
state health insurance exchanges under Health Care Reform, which
have experienced and continue to experience challenges due to
implementation of initial and phased-in provisions of Health Care
Reform, and which entail uncertainties associated with the mix
and volume of business, particularly in our Individual and Small
Group markets, that could negatively impact the adequacy of our
premium rates and which may not be sufficiently offset by the
risk apportionment provisions of Health Care Reform; the ultimate
outcome of our pending acquisition of Cigna Corporation (Cigna)
(the Acquisition), including our ability to achieve the synergies
and value creation contemplated by the Acquisition within the
expected time period, or at all, and the risk that unexpected
costs will be incurred in connection therewith; the ultimate
outcome and results of integrating our and Cignas operations and
disruption from the Acquisition making it more difficult to
maintain businesses and operational relationships; the
possibility that the Acquisition does not close, including, but
not limited to, due to the failure to satisfy the closing
conditions, including the receipt of required regulatory
approvals; the risks and uncertainties detailed by Cigna with
respect to its business as described in its reports and documents
filed with the SEC; our ability to contract with providers on
cost-effective and competitive terms; competitor pricing below
market trends of increasing costs; reduced enrollment, as well as
a negative change in our health care product mix; risks and
uncertainties regarding Medicare and Medicaid programs, including
those related to non-compliance with the complex regulations
imposed thereon and funding risks with respect to revenue
received from participation therein; a downgrade in our financial
strength ratings; increases in costs and other liabilities
associated with increased litigation, government investigations,
audits or reviews; medical malpractice or professional liability
claims or other risks related to health care services provided by
our subsidiaries; our ability to repurchase shares of our common
stock and pay dividends on our common stock due to the adequacy
of our cash flow and earnings and other considerations;
non-compliance by any party with the Express Scripts, Inc.
pharmacy benefit management services agreement, which could
result in financial penalties, our inability to meet customer
demands, and sanctions imposed by governmental entities,
including the Centers for Medicare and Medicaid Services; events
that result in negative publicity for us or the health benefits
industry; failure to effectively maintain and modernize our
information systems; events that may negatively affect our
licenses with the Blue Cross and Blue Shield Association; state
guaranty fund assessments for insolvent insurers; possible
impairment of the value of our intangible assets if future
results do not adequately support goodwill and other intangible
assets; intense competition to attract and retain employees;
unauthorized disclosure of member or employee sensitive or
confidential information, including the impact and outcome of
investigations, inquiries, claims and litigation related to the
cyber-attack we reported in February 2015; changes in economic
and market conditions, as well as regulations that may negatively
affect our investment portfolios and liquidity; possible
restrictions in the payment of dividends by our subsidiaries and
increases in required minimum levels of capital and the potential
negative effect from our substantial amount of outstanding
indebtedness; general risks associated with mergers, acquisitions
and strategic alliances; various laws and provisions in our
governing documents that may prevent or discourage takeovers and
business combinations; future public health epidemics and
catastrophes; and general economic downturns. Readers are
cautioned not to place undue reliance on these forward-looking
statements that speak only as of the date hereof. We do not
undertake to update or revise any forward-looking statements,
except as required by applicable securities laws. Investors are
also advised to carefully review and consider the various risks
and other disclosures discussed in our SEC reports.

About ANTHEM, INC. (NYSE:ANTM)
Anthem, Inc. is a health benefit company. The Company offers a range of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. The Company has three segments: Commercial and Specialty Business, Government Business and Other. The Company’s Commercial and Specialty Business, and Government Business segments offer managed care products, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), traditional indemnity benefits and point-of-service (POS) plans, as well as various hybrid benefit plans, including consumer-driven health plans (CDHPs), hospital only and limited benefit products. In addition, the Company also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. ANTHEM, INC. (NYSE:ANTM) Recent Trading Information
ANTHEM, INC. (NYSE:ANTM) closed its last trading session down -1.59 at 142.79 with 907,110 shares trading hands.

Exit mobile version